AMRI moves suburban Seattle laboratory to larger space

Albany Molecular Research Inc. said this morning it has moved its research unit in Washington state into 44,000 square feet of newly refurbished laboratory and office space near its former lab.

The Albany-based pharmaceutical and contract drug discovery firm said the new space will be more efficient and give it room to grow.

The facility in the Seattle suburb of Bothell currently employs 40 people, AMRI spokeswoman Andrea Schulz said, and the company plans to increase staff there “over time.” The former laboratory was 36,000 square feet.

Thomas D’Ambra, AMRI chairman, CEO and president, said the new space will provide “significant cost savings” while providing room for growth.

“In this current business climate, we believe the pharmaceutical industry will continue to be challenged to simultaneously contain costs while continuing to populate new drug pipelines, resulting in an increased demand for outsourcing services,” D’Ambra said.

Overall, AMRI has 1,351 employees, with facilities in the Capital Region, Washington state, India, Singapore and Hungary. In the Capital Region, it employs 781 people.